|
SEPT7P2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87738713464114E-13 |
| Normal-vs-Stage2 |
4.16330000000409E-05 |
| Normal-vs-Stage3 |
9.85039999568116E-08 |
| Normal-vs-Stage4 |
8.352500E-04 |
| Stage1-vs-Stage2 |
5.756200E-01 |
| Stage1-vs-Stage3 |
7.727000E-01 |
| Stage1-vs-Stage4 |
2.307400E-01 |
| Stage2-vs-Stage3 |
7.800600E-01 |
| Stage2-vs-Stage4 |
1.983240E-01 |
| Stage3-vs-Stage4 |
2.362000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.6621374255883E-15 |
| Normal-vs-AfricanAmerican |
9.48930000022052E-07 |
| Normal-vs-Asian |
1.248350E-02 |
| Caucasian-vs-AfricanAmerican |
3.596200E-01 |
| Caucasian-vs-Asian |
3.631700E-02 |
| AfricanAmerican-vs-Asian |
6.843800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82986958918718E-12 |
| Normal-vs-Female |
1.78856929267113E-13 |
| Male-vs-Female |
2.412600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.252300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.0522472610196E-12 |
| Normal-vs-Age(61-80Yrs) |
4.69859706697662E-11 |
| Normal-vs-Age(81-100Yrs) |
1.996260E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.783600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.704200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.308400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.549000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.775600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.715200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.014450E-04 |
| Normal-vs-Grade 2 |
1.75781611488901E-12 |
| Normal-vs-Grade 3 |
1.42129996660856E-09 |
| Normal-vs-Grade 4 |
1.823840E-03 |
| Grade 1-vs-Grade 2 |
4.103400E-01 |
| Grade 1-vs-Grade 3 |
5.158200E-02 |
| Grade 1-vs-Grade 4 |
8.651600E-02 |
| Grade 2-vs-Grade 3 |
4.647600E-02 |
| Grade 2-vs-Grade 4 |
1.627960E-01 |
| Grade 3-vs-Grade 4 |
9.105200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.76825221132049E-12 |
| Normal-vs-ccB subtype |
6.99250000124607E-08 |
| ccA subtype-vs-ccB subtype |
2.821200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.42350584045425E-12 |
| Normal-vs-N1 |
2.104800E-01 |
| N0-vs-N1 |
3.137000E-01 |
|
|
